Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)

Detalles Bibliográficos
Autores principales: Daniels, Benjamin, Pearson, Sallie-Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Swansea University 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362409/
http://dx.doi.org/10.23889/ijpds.v1i1.142
_version_ 1783738155518656512
author Daniels, Benjamin
Pearson, Sallie-Anne
author_facet Daniels, Benjamin
Pearson, Sallie-Anne
author_sort Daniels, Benjamin
collection PubMed
description
format Online
Article
Text
id pubmed-8362409
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Swansea University
record_format MEDLINE/PubMed
spelling pubmed-83624092021-09-09 Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC) Daniels, Benjamin Pearson, Sallie-Anne Int J Popul Data Sci Article Swansea University 2017-04-19 /pmc/articles/PMC8362409/ http://dx.doi.org/10.23889/ijpds.v1i1.142 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Daniels, Benjamin
Pearson, Sallie-Anne
Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
title Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
title_full Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
title_fullStr Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
title_full_unstemmed Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
title_short Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
title_sort opportunities for post-market surveillance of high cost medicines in australia: observing trastuzumab-treated women from early through late stage her2-positive breast cancer (her2bc)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362409/
http://dx.doi.org/10.23889/ijpds.v1i1.142
work_keys_str_mv AT danielsbenjamin opportunitiesforpostmarketsurveillanceofhighcostmedicinesinaustraliaobservingtrastuzumabtreatedwomenfromearlythroughlatestageher2positivebreastcancerher2bc
AT pearsonsallieanne opportunitiesforpostmarketsurveillanceofhighcostmedicinesinaustraliaobservingtrastuzumabtreatedwomenfromearlythroughlatestageher2positivebreastcancerher2bc

Ejemplares similares